ClassID:

109145

C12N2310/14 - page 16 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.

Recent Application in this class:
#4501
20170296524
2017-10-19

Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases

#4502
20170292959
2017-10-12

PLASMIDS COMPRISING INTERNAL RIBOSOMAL ENTRY SITES AND USES THEREOF

#4503
20170292128
2017-10-12

Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases

#4504
20170291956
2017-10-12

HER3 Inhibition in Low-grade Serous Ovarian Cancers

#4505
20170290821
2017-10-12

ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT

#4506
20170283827
2017-10-05

FSH nucleic acid molecules to control insect pests

#4507
20170283817
2017-10-05

Polypeptides having beta-xylosidase activity and polynucleotides encoding same

#4508
20170283814
2017-10-05

BIOLOGICAL CONTROLS OF COLEOPTERAN PESTS

#4509
20170283807
2017-10-05

Compositions and methods for diagnosis and treatment of prostate cancer

#4510
20170283806
2017-10-05

KRAS nucleic acids and uses thereof

#4511
20170283803
2017-10-05

RNA interference compositions targeting heat shock protein 90 and methods of use thereof

#4512
20170283802
2017-10-05

DESIGN OF NUCLEIC ACID BINDING MOLECULES WITH NON-WATSON CRICK AND NON-CANONICAL PAIRING BASED ON ARTIFICIAL MUTATION CONSENSUS SEQUENCES TO COUNTER ESCAPE MUTATIONS

#4513
20170283801
2017-10-05

Therapeutic compositions

#4514
20170283509
2017-10-05

Blocking monoclonal antibodies to AGR2 and its receptor C4.4A

#4515
20170283502
2017-10-05

Compositions and methods for treating and preventing inflammation

#4516
20170283467
2017-10-05

Programmable polypeptide and nucleic acid nanoparticles

#4517
20170281795
2017-10-05

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

#4518
20170281628
2017-10-05

Molecular targets for the treatment of wounds, in particular chronic wounds

#4519
20170275629
2017-09-28

Methods and compositions for the treatment of cancer

#4520
20170275627
2017-09-28

Chimeric single-stranded antisense polynucleotides and double-stranded antisense agent

#4521
20170275626
2017-09-28

Modified double-stranded RNA agents

#4522
20170275623
2017-09-28

Cancer treatment and immune system regulation through FAT10 pathway inhibition

#4523
20170275621
2017-09-28

Chiral control

#4524
20170275619
2017-09-28

Compositions and methods for treating vascular disorders

#4525
20170275618
2017-09-28

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF MYC BY DOUBLE-STRANDED RNA

#4526
20170275591
2017-09-28

Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting NOX-1

#4527
20170274000
2017-09-28

Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles

#4528
20170269093
2017-09-21

Methods for identifying and treating invasive/metastatic breast cancers

#4529
20170269091
2017-09-21

Method and treatment of recurring endometrial cancer with an inhibitor of USP14

#4530
20170268019
2017-09-21

Methods and compositions for preventing or reducing infections of crop plants by bacterial and fungal pathogens

#4531
20170268008
2017-09-21

DIAGNOSTIC AND THERAPEUTIC TARGETING OF DNMT-1 ASSOCIATED RNA IN HUMAN CANCER

#4532
20170268005
2017-09-21

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#4533
20170268002
2017-09-21

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#4534
20170266280
2017-09-21

Approach for treatment of cancer via immunomodulation by using talabostat

#4535
20170266140
2017-09-21

Compositions for modulating cancer stem cells and uses therefor

#4536
20170260593
2017-09-14

Methods for sub-typing and treating cancer

#4537
20170260592
2017-09-14

Next generation RNA-sequencing and long non-coding RNA in glioblastoma multiforme

#4538
20170260533
2017-09-14

MUCOSAL HEALING PROMOTER

#4539
20170260532
2017-09-14

Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-λ gene activity

#4540
20170260529
2017-09-14

POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING

#4541
20170260528
2017-09-14

Delivery of dsRNA to arthropods

#4542
20170260527
2017-09-14

Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof

#4543
20170260525
2017-09-14

Methods of treating, inhibiting and/or preventing an auditory impairment

#4544
20170260523
2017-09-14

NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY

#4545
20170260522
2017-09-14

Compositions and methods for controlling insect pests

#4546
20170258938
2017-09-14

Exosome transfer of nucleic acids to cells

#4547
20170258734
2017-09-14

Bacterially derived intact minicells that encompass plasmid free DNA and methods of using the same

#4548
20170254799
2017-09-07

Method for determining the repair activity of non-homologous end joining

#4549
20170253887
2017-09-07

COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS

#4550
20170253882
2017-09-07

Target of VGSC β3 protein for prevention, treatment and diagnostic detection of cancers

#4551
20170253881
2017-09-07

COMPOSITIONS AND METHODS OF SELECTIVELY INHIBITING IRP1 AND TREATING INFLAMMATION

#4552
20170253879
2017-09-07

APTAMER-RNAi THERAPEUTIC COMPOSITIONS

#4553
20170253875
2017-09-07

Targeting ligands for therapeutic compounds

#4554
20170253874
2017-09-07

COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF

#4555
20170253873
2017-09-07

Polypeptide inhibitors of Smad3 polypeptide activities

#4556
20170252376
2017-09-07

NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE

#4557
20170248610
2017-08-31

Method of predicting obesity comprising measuring neurotensin

#4558
20170248578
2017-08-31

ANTI-CANCER AGENT SENSITIVITY-DETERMINING MARKER

#4559
20170247718
2017-08-31

Methods and compositions for root knot nematode control

#4560
20170247707
2017-08-31

Interfering RNA molecules

#4561
20170247706
2017-08-31

CDC25A inhibitor for the treatment of drug resistant cancer or for the prevention of tumor relapse

#4562
20170247701
2017-08-31

NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPI

#4563
20170247700
2017-08-31

NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPI

#4564
20170247698
2017-08-31

Interfering RNA molecules

#4565
20170247697
2017-08-31

Interfering RNA molecules

#4566
20170247696
2017-08-31

MICRORNA WITH PLACENTA-PERMEABILITY AND USES THEREOF

#4567
20170247692
2017-08-31

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS

#4568
20170247691
2017-08-31

Interfering RNA molecules

#4569
20170246309
2017-08-31

Polyol-based osmotic polydixylitol polymer gene transporter and use thereof

#4570
20170242015
2017-08-24

MAP3K8 AS A MARKER FOR SELECTING A PATIENT AFFECTED WITH AN OVARIAN CANCER FOR A TREATMENT WITH A MEK INHIBITOR

#4571
20170240966
2017-08-24

PREDICTING AMD WITH SNPS WITHIN OR NEAR C2, FACTOR B, PLEKHA1, HTRA1, PRELP, OR LOC387715

#4572
20170240913
2017-08-24

Methods and Materials for Producing Coreless Fruit

#4573
20170240905
2017-08-24

IMPAIRED WOUND HEALING COMPOSITION AND TREATMENTS

#4574
20170240903
2017-08-24

Modulation of breast cancer growth by modulation of XBP1 activity

#4575
20170240902
2017-08-24

Method and composition for the treatment, prevention, and diagnosis of cancer containing or derived from cancer stem cells

#4576
20170240901
2017-08-24

NUCLEIC ACIDS, AND USES THEROF

#4577
20170240899
2017-08-24

Multiplexed shRNAs and uses thereof

#4578
20170240890
2017-08-24

GNAQ targeted dsRNA compositions and methods for inhibiting expression

#4579
20170240889
2017-08-24

DNA-RNA hybrid particles and manufacturing method thereof

#4580
20170240867
2017-08-24

VITAMIN K EPOXIDE RECYCLING POLYPEPTIDE VKORC1, A THERAPEUTIC TARGET OF COUMARIN AND THEIR DERIVATIVES

#4581
20170239322
2017-08-24

Compositions and methods for enhancing cardiac function in the neonate

#4582
20170239284
2017-08-24

Antibody-siRNA conjugates and uses therefor

#4583
20170239200
2017-08-24

Small molecule inhibitors of RNA binding motif (RBM) proteins for the treatment of acute cellular injury

#4584
20170233760
2017-08-17

BIOLOGICALLY ACTIVE NUCLEOTIDE MOLECULES FOR SELECTIVELY KILLING OFF CELLS, USE THEREOF, AND APPLICATION KIT

#4585
20170233745
2017-08-17

UREIDOPYRIMIDONE SUPRAMOLECULAR COMPLEXES FOR COMPOUND DELIVERY INTO CELLS

#4586
20170233743
2017-08-17

Compositions for controlling mites in bees

#4587
20170233742
2017-08-17

Compositions Comprising Small Interfering RNA Molecules for Prevention and Treatment of Ebola Virus Disease

#4588
20170233735
2017-08-17

Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAS targeting the expanded hexanucleotide repeat

#4589
20170233734
2017-08-17

NUCLEIC ACID LIPID PARTICLE FORMULATIONS

#4590
20170233733
2017-08-17

Twist signaling inhibitor compositions and methods of using the same

#4591
20170233731
2017-08-17

Tetragalnac containing conjugates and methods for delivery of oligonucleotides

#4592
20170232115
2017-08-17

POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY INCLUDING TRANSDERMAL DELIVERY OF CARGO AND METHODS THEREOF

#4593
20170227543
2017-08-10

Breast Tumor Markers And Methods Of Use Thereof

#4594
20170226596
2017-08-10

DETECTION OF VIRAL INFECTION

#4595
20170226550
2017-08-10

INHIBITORY RNA FOR ENHANCED PROTEIN PRODUCTION IN RECOMBINANT MAMMALIAN CELLS

#4596
20170226520
2017-08-10

PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition

#4597
20170226519
2017-08-10

METHODS OF TREATING ISCHEMIA-REPERFUSION INJURY WITH siRNAS

#4598
20170226516
2017-08-10

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

#4599
20170226514
2017-08-10

PREVENTION OF TUMOUR METASTASIS BY INHIBITION OF NECROPTOSIS

#4600
20170226512
2017-08-10

Nucleic acid aptamers

#4601
20170226505
2017-08-10

Method for improving memory using CCNY inhibitor

#4602
20170224619
2017-08-10

Cationic lipid

#4603
20170219594
2017-08-03

Screening method

#4604
20170219591
2017-08-03

PANCREATIC CANCER TARGETS AND USES THEREOF

#4605
20170218391
2017-08-03

GAWKY (GW) NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS

#4606
20170218390
2017-08-03

RPB7 NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS

#4607
20170218385
2017-08-03

Methods for preparing pecific polypeptide-binding antibodies

#4608
20170218376
2017-08-03

Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1

#4609
20170218374
2017-08-03

Treatment of angiogenesis-associated diseases using RNA complexes that target ANGPT2 and PDGFB

#4610
20170218373
2017-08-03

Composition for diagnosis of liver metastasis of colorectal cancer and the use thereof

#4611
20170218365
2017-08-03

METHODS FOR MALIGNANT TUMORS WITH RNAI MOLECULES TARGETED TO HSP47

#4612
20170218360
2017-08-03

OLIGONUCLEOTIDES FOR MODULATING TARGET RNA ACTIVITY

#4613
20170216227
2017-08-03

DELIVERY MOLECULES FOR THERAPEUTICS

#4614
20170215392
2017-08-03

Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo

#4615
20170211144
2017-07-27

Administration of FGF9 for treatment and prevention of major depression

#4616
20170211072
2017-07-27

Methods and compositions for inhibiting growth and epithelial to mesenchymal transition (EMT) in cancer cells

#4617
20170211071
2017-07-27

Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF

#4618
20170211070
2017-07-27

Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva

#4619
20170211048
2017-07-27

ENHANCED REPROGRAMMING TO IPS CELLS

#4620
20170209392
2017-07-27

Honey bee mite disruptive compounds and methods of application

#4621
20170205415
2017-07-20

BARD1 isoforms in lung and colorectal cancer and use thereof

#4622
20170204468
2017-07-20

USE OF H2A.Z.1 AS A HEPATOCELLULAR CARCINOMA BIOMARKER

#4623
20170204432
2017-07-20

METHODS FOR OPTIMIZING ELECTROPORATION

#4624
20170204419
2017-07-20

MrgprX2/MrgprB2 expressing cell based assay to detect pseudo-allergic drug reactions and to identify blockers to prevent the adverse reactions

#4625
20170204417
2017-07-20

dsRNA for treating viral infection

#4626
20170204411
2017-07-20

Methods and compositions for treating insects

#4627
20170204408
2017-07-20

Compositions for Targeted Delivery of siRNA

#4628
20170204396
2017-07-20

Method for secretion of extracellular vesicles from cells and tissues using shock wave

#4629
20170204375
2017-07-20

Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells

#4630
20170204076
2017-07-20

SYNTHESIS AND USE OF AMINO LIPIDS

#4631
20170204075
2017-07-20

Aminoalcohol lipidoids and uses thereof

#4632
20170202867
2017-07-20

Methods of inhibiting cancer stem cells with HMGA1 inhibitors

#4633
20170198357
2017-07-13

R2R1/2 in diagnosis and therapy

#4634
20170198306
2017-07-13

ENGINEERING MAMMALIAN GENOME USING DNA-GUIDED ARGONAUTE INTERFERENCE SYSTEMS (DAIS)

#4635
20170198295
2017-07-13

Nurr1 as a genetic target for treating levodopa-induced dyskinesias in Parkinson's disease

#4636
20170198294
2017-07-13

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

#4637
20170198293
2017-07-13

Preventive or therapeutic agent for fibrosis

#4638
20170198292
2017-07-13

Methods and Compositions for Modulating Lung Cancer Tumor Initiating Cells (TIC), and Oxytocin Receptor (OXTR) Modulatory Agents for Use in Practicing the Same

#4639
20170198291
2017-07-13

COMPOSITION FOR TREATING CANCER ASSOCIATED WITH HPV INFECTION

#4640
20170198055
2017-07-13

Diagnostic and therapeutic tool for cancer

#4641
20170198026
2017-07-13

Compositions And Methods For Treating Tumors And Immune Based Inflammatory Diseases

#4642
20170197903
2017-07-13

Cationic lipid

#4643
20170196836
2017-07-13

Lung cancer adjuvant therapy

#4644
20170196809
2017-07-13

Method of encapsulating a nucleic acid in a lipid nanoparticle host

#4645
20170192006
2017-07-06

Biomarkers for human monocyte myeloid-derived suppresor cells

#4646
20170191102
2017-07-06

Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase

#4647
20170191080
2017-07-06

Solid Phase Transfection of Proteins and Nucleic Acids

#4648
20170191065
2017-07-06

COMPOSITIONS AND METHODS OF USING SAME FOR INCREASING RESISTANCE OF INFECTED MOSQUITOES

#4649
20170191063
2017-07-06

Targeting the steroidogenic pathway for treating and/or preventing allergic diseases

#4650
20170191058
2017-07-06

PERFORIN 2 DEFENSE AGAINST INVASIVE AND MULTIDRUG RESISTANT PATHOGENS

#4651
20170191057
2017-07-06

RNA EDITING BIOMARKERS FOR DIAGNOSIS, PHARMACOLOGICAL SCREENING AND PROGNOSTICATION IN CANCER

#4652
20170189541
2017-07-06

Angiotensinogen (AGT) iRNA compositions and methods of use thereof

#4653
20170189496
2017-07-06

USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL

#4654
20170189404
2017-07-06

Bruton's tyrosine kinase as anti-cancer drug target

#4655
20170183686
2017-06-29

Exosomal loading using hydrophobically modified oligonucleotides

#4656
20170183683
2017-06-29

Compositions and methods for controlling insect pests

#4657
20170183662
2017-06-29

Methods and compositions for treating neuropathic pain

#4658
20170183659
2017-06-29

Polynucleotide agents targeting complement component C5 and methods of use thereof

#4659
20170183658
2017-06-29

Use of miR-199a-5p, targets and/or inhibitors thereof for the diagnosis, prognosis and treatment of fibroproliferative disorders

#4660
20170183657
2017-06-29

Method of separating senescent cells using overexpression of protocadherin

#4661
20170183656
2017-06-29

Composition including pint gene expression inhibitor or pint activity inhibitor and use thereof

#4662
20170183652
2017-06-29

LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY

#4663
20170182182
2017-06-29

Composition for delivery of genetic material

#4664
20170182076
2017-06-29

METHODS OF TREATING MITOCHONDRIAL DYSFUNCTION

#4665
20170175137
2017-06-22

Retroviral vector having immune-stimulating activity

#4666
20170175133
2017-06-22

COMPOSITIONS AND METHODS FOR THE SUPPRESSION OF TARGET POLYNUCLEOTIDES FROM LEPIDOPTERA

#4667
20170175132
2017-06-22

Ribosomal protein L40 (RPL40) nucleic acid molecules that confer resistance to coleopteran and hemipteran pests

#4668
20170175127
2017-06-22

Methods of treating cancer

#4669
20170175126
2017-06-22

Exon skipping technology in VCP disease

#4670
20170175125
2017-06-22

Inhibition of Bruton's tyrosine kinase (Btk) in the lung to treat severe lung inflammation and lung injury

#4671
20170175124
2017-06-22

INDIVIDUALIZED CANCER THERAPY

#4672
20170175120
2017-06-22

Methods of controlling cell fate and consequences for disease

#4673
20170175119
2017-06-22

Lepidopteran moth control using double-stranded RNA constructs

#4674
20170175118
2017-06-22

Composition and method of using miR-302 precursors as anti-cancer drugs for treating human lung cancer

#4675
20170175115
2017-06-22

Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier

#4676
20170175113
2017-06-22

Methods for modulating Ataxin 2 expression

#4677
20170173173
2017-06-22

Skin Permeating and Cell Entering (SPACE) Peptides and Methods of Use Thereof

#4678
20170172936
2017-06-22

Drug delivery particle and method for producing the same

#4679
20170166972
2017-06-15

LONG NON-CODING RNA AS A DIAGNOSTIC AND THERAPEUTIC AGENT

#4680
20170166901
2017-06-15

METHOD FOR OPENING TIGHT JUNCTIONS

#4681
20170166898
2017-06-15

siRNA structures for high activity and reduced off target

#4682
20170166897
2017-06-15

COMPOSITIONS AND METHODS FOR TARGETING O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE AND PROMOTING WOUND HEALING

#4683
20170166896
2017-06-15

Treatment of Liver Cancer through Embolization Depot Delivery of BORIS Gene Silencing Agents

#4684
20170166893
2017-06-15

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#4685
20170166892
2017-06-15

Methods for the treatment of cardiovascular fibrosis

#4686
20170166891
2017-06-15

METHODS OF TREATING A METABOLIC SYNDROME BY MODULATING HEAT SHOCK PROTEIN (HSP) 90-BETA

#4687
20170165289
2017-06-15

Methods and compositions for treating malignant tumors associated with kras mutation

#4688
20170165200
2017-06-15

COMPOSITION OF LIPID-BASED NANOPARTICLES FOR SMALL MOLECULES AND MACROMOLECULES

#4689
20170159057
2017-06-08

COMPOSITIONS AND METHODS FOR MODULATION OF RORGAMMAT FUNCTIONS

#4690
20170159054
2017-06-08

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#4691
20170159053
2017-06-08

Methods and compositions for treating a Serpinc1-associated disorder

#4692
20170159051
2017-06-08

Small interfering RNA and pharmaceutical composition and method for inhibiting galectin-12 expression and/or enhancing lipolysis containing the same

#4693
20170157381
2017-06-08

Medical devices for delivery of siRNA

#4694
20170157230
2017-06-08

Modified natural killer cells and natural killer cell lines having increased cytotoxicity

#4695
20170157218
2017-06-08

Methods of treating fragile X syndrome and related disorders

#4696
20170153240
2017-06-01

Composition, kit, and method for diagnosing and treating ovarian cancer

#4697
20170152516
2017-06-01

Method of producing lipid nanoparticles for drug delivery

#4698
20170152514
2017-06-01

Methods for triggering de novo formation of heterochromatin and or epigenetic silencing with small RNAS

#4699
20170152513
2017-06-01

Modulation of BCL11A for treatment of hemoglobinopathies

#4700
20170152512
2017-06-01

Nanoparticle type oligonucleotide structure having high efficiency and method for preparing same

#4701
20170152223
2017-06-01

LIPID PARTICLES WITH CATIONIC LIPIDS FOR RNA DELIVERY

#4702
20170151322
2017-06-01

Cell lines for virus production and methods of use

#4703
20170151262
2017-06-01

Ship inhibition to induce activation of natural killer cells

#4704
20170146520
2017-05-25

METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

#4705
20170146518
2017-05-25

Use of compounds inhibiting apelin / APJ / GP130 signaling for treating cancer

#4706
20170145439
2017-05-25

Multicistronic expression constructs

#4707
20170145426
2017-05-25

Modular construction of synthetic gene circuits in mammalian cells using TALE transcriptional repressors

#4708
20170145423
2017-05-25

Use of Mcoln-1 modulators to regulate cell migration

#4709
20170145422
2017-05-25

Double stranded RNA constructs for aphid control

#4710
20170145419
2017-05-25

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

#4711
20170145418
2017-05-25

Combination of Anti-Clusterin Oligonucleotide with HSP90 Inhibitor for the Treatment of Prostate Cancer

#4712
20170145415
2017-05-25

Transferrin/transferrin receptor-mediated siRNA delivery

#4713
20170145414
2017-05-25

Treatment of Frataxin (FXN) related diseases by inhibition of natural antisense transcript to FXN

#4714
20170145411
2017-05-25

Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2

#4715
20170144967
2017-05-25

Ionizable cationic lipid for RNA delivery

#4716
20170143825
2017-05-25

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

#4717
20170143686
2017-05-25

Pharmaceutical composition for preventing or treating neurodegenerative diseases

#4718
20170143641
2017-05-25

Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof

#4719
20170143639
2017-05-25

NANOCOMPOSITES OF GOLD AND POLYMERS

#4720
20170143631
2017-05-25

LIPID FORMULATION

#4721
20170137841
2017-05-18

Double strand RNA-mediated RNA interference through feeding detrimental to larval (gypsy moth)

#4722
20170137828
2017-05-18

Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3

#4723
20170137827
2017-05-18

Compositions and methods for inhibiting expression of RRM2 genes

#4724
20170137825
2017-05-18

Apoptosis inducer

#4725
20170137824
2017-05-18

NEW TREATMENT AGAINST INFLUENZA VIRUS

#4726
20170137823
2017-05-18

Inhibition of PCSK9 through RNAI

#4727
20170137821
2017-05-18

MOLECULES AND AGENTS FOR TREATING HEPATITIS B VIRUS

#4728
20170137815
2017-05-18

NOVEL SINGLE CHEMICAL ENTITIES AND METHODS FOR DELIVERY OF OLIGONUCLEOTIDES

#4729
20170137814
2017-05-18

Organic compositions to treat APOC3-related diseases

#4730
20170137809
2017-05-18

Nucleic acid functionalized nanoparticles for therapeutic applications

#4731
20170137808
2017-05-18

IMPROVED SMALL INTERFERING RIBONUCLEIC ACID MOLECULES

#4732
20170137409
2017-05-18

Amine cationic lipids and uses thereof

#4733
20170136053
2017-05-18

Pharmaceutical composition and uses thereof

#4734
20170131282
2017-05-11

Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer

#4735
20170131280
2017-05-11

METHODS, ASSAYS, AND SYSTEMS RELATING TO SAKT

#4736
20170130246
2017-05-11

Trans-acting elements for intracellular delivery of nucleic acid sequences

#4737
20170130243
2017-05-11

SHIBIRE/DYNAMIN NUCLEIC ACID MOLECULES TO CONTROL COLEOPTERAN AND HEMIPTERAN PESTS

#4738
20170130232
2017-05-11

Methods for immortalization of epithelial cells

#4739
20170130231
2017-05-11

Double-stranded oligo RNA targeted to amphiregulin and pharmaceutical composition comprising same for preventing or treating fibrosis or respiratory diseases

#4740
20170130230
2017-05-11

Methods of using PVT1 exon 9 to diagnose and treat prostate cancer

#4741
20170130228
2017-05-11

Compositions and methods to activate or inhibit toll-like receptor signaling

#4742
20170130225
2017-05-11

Modified oligonucleotides for telomerase inhibition

#4743
20170130223
2017-05-11

Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancer

#4744
20170130222
2017-05-11

Small molecules that enhance the activity of oligonucleotides

#4745
20170130221
2017-05-11

Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA

#4746
20170129960
2017-05-11

Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels

#4747
20170129932
2017-05-11

METHOD FOR PREPARING RECOMBINANT GLYCOPROTEIN HAVING HIGH SIALIC ACID CONTENT, THROUGH GLYCOSPHINGOLIPID SYNTHESIS CYCLE CONTROL

#4748
20170128582
2017-05-11

Peptide sequence design and use thereof for peptide-mediated siRNA delivery

#4749
20170128461
2017-05-11

SHIP INHIBITION TO INDUCE EXPRESSION OF GRANULOCYTE COLONY STIMULATING FACTOR IN A SUBJECT

#4750
20170128367
2017-05-11

Liposomal formulations for delivery of nucleic acids

#4751
20170121742
2017-05-04

Algal mutants with increased lipid productivity

#4752
20170121714
2017-05-04

METHOD FOR PRODUCING LIPID PARTICLES AND NUCLEIC ACID DELIVERY CARRIER HAVING LIPID PARTICLES

#4753
20170121712
2017-05-04

NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS

#4754
20170121708
2017-05-04

Multifunctional RNA nanoparticles and methods of use

#4755
20170121707
2017-05-04

Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves

#4756
20170121369
2017-05-04

Inhibitors of metastasis

#4757
20170119900
2017-05-04

Peptide, complex of peptide and siRNA and use thereof

#4758
20170119887
2017-05-04

Lipid particles and nucleic acid delivery carrier

#4759
20170114412
2017-04-27

Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2

#4760
20170114365
2017-04-27

Method for expression of small RNA molecules within a cell

#4761
20170114344
2017-04-27

Reduction of TGFβ signaling in myeloid cells in the treatment of cancer

#4762
20170114342
2017-04-27

Serpina1 iRNA compositions and methods of use thereof

#4763
20170114341
2017-04-27

POLYNUCLEOTIDE CONSTRUCTS HAVING BIOREVERSIBLE AND NON-BIOREVERSIBLE GROUPS

#4764
20170114340
2017-04-27

RAAV-based compositions and methods for treating amyotrophic lateral sclerosis

#4765
20170114132
2017-04-27

Use of negative functional modulators of erythropoietin for therapy

#4766
20170114124
2017-04-27

SLIT-ROBO-Myo9-RHOA PATHWAY AND CANCER

#4767
20170114010
2017-04-27

Ionizable cationic lipid for RNA delivery

#4768
20170112973
2017-04-27

Delivery of hydrophobic active agent particles

#4769
20170112929
2017-04-27

VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER

#4770
20170112760
2017-04-27

CELL DELIVERY SYSTEM AND METHOD

#4771
20170112110
2017-04-27

All sterile males of culicine mosquitoes: a method of creation

#4772
20170107578
2017-04-20

COMPOSITIONS, METHODS AND KITS FOR CHARACTERIZING AND SCREENING FOR SMALL CELL OVARIAN CARCINOMA

#4773
20170107521
2017-04-20

Pharmaceutical composition for treating chronic kidney disease

#4774
20170107519
2017-04-20

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

#4775
20170107513
2017-04-20

Monomers and oligonucleotides comprising cycloaddition adduct(s)

#4776
20170107511
2017-04-20

Oligonucleotide end caps

#4777
20170107271
2017-04-20

Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)

#4778
20170106076
2017-04-20

Transmission blocking vaccines for mosquito-borne

#4779
20170106008
2017-04-20

STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases

#4780
20170105980
2017-04-20

Methods For Treating Nicotinic Acetylcholine Receptor Associated Diseases

#4781
20170101644
2017-04-13

Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) autosomal dominant osteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation

#4782
20170101642
2017-04-13

METHODS OF INHIBITING VIRAL REPLICATION COMPRISING THE SIGNAL PEPTIDASE COMPLEX

#4783
20170101641
2017-04-13

Modulation of gene expression and screening for deregulated protein expression

#4784
20170101640
2017-04-13

Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)

#4785
20170101639
2017-04-13

RNAi PHARMACEUTICAL COMPOSITION FOR SUPPRESSING EXPRESSION OF CKAP5 GENE

#4786
20170100486
2017-04-13

Compounds and methods for trans-membrane delivery of molecules

#4787
20170100482
2017-04-13

Lipocationic polymers and uses thereof

#4788
20170100462
2017-04-13

Genomic instability markers in Fanconi anemia

#4789
20170100458
2017-04-13

Use of CPNE7 for differentiating non-dental mesenchymal stem cells into odontoblasts, regenerating dental pulp and treating dentin hypersensitivity

#4790
20170100385
2017-04-13

PHARMACEUTICAL COMPOSITIONS COMPRISING DANIRIXIN FOR TREATING INFECTIOUS DISEASES

#4791
20170096667
2017-04-06

INHIBITING GENE EXPRESSION WITH dsRNA

#4792
20170096665
2017-04-06

Compositions and methods for inhibiting gene expression of LPA

#4793
20170096663
2017-04-06

siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis

#4794
20170096517
2017-04-06

Diblock copolymers and polynucleotide complexes thereof for delivery into cells

#4795
20170096486
2017-04-06

AGENTS INHIBITING GRANULIN FOR TREATMENT OF CANCER

#4796
20170088857
2017-03-30

Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling

#4797
20170088838
2017-03-30

Compositions and methods for controlling arthropod parasite and pest infestations

#4798
20170088619
2017-03-30

Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells

#4799
20170087166
2017-03-30

METHODS FOR TREATING AND PREVENTING ALLERGIES AND ACUTE ALLERGIC RESPONSES

#4800
20170081671
2017-03-23

Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy